DEVICES AND METHODS FOR ANALYZING BIOMOLECULES AND PROBES BOUND THERETO

• US 20100243449A1
• Filed: 03/26/2010
• Published: 09/30/2010
• Est. Priority Date: 03/27/2009
• Status: Abandoned Application

• Current Assignee: NABsys, Inc.
• Original Assignee: NABsys, Inc.
• Inventors: Oliver, John S.
• Application Number:
  US12/732,870
• Publication Number:
  US 20100243449A1
• Time in Patent Office: Days
• US Class Current: 204/450
• CPC Class Codes: B01L 3/502761 specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules investigating characteristics of particles G01N15/00
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/6825 Nucleic acid detection involving sensors
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2522/101 Single or double stranded nucleic acid binding proteins
• CPC Class Codes: C12Q 2565/629 being a microfluidic device
• CPC Class Codes: C12Q 2565/631 being a biochannel or pore
• CPC Class Codes: G01N 33/48721 Investigating individual macromolecules, e.g. by translocation through nanopores Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68

Abstract

Devices and methods for sequencing biomolecules include improving signal-to-noise ratio of detection of relative positions of probes hybridized to a biomolecule by coating at least a portion of the biomolecule with a protein prior to its translocation through a structure defining a nanopore, microchannel or nanochannel.

Claims

1. A method for mapping a target biomolecule, the method comprising the steps of:

a) providing a single-stranded or double-stranded target biomolecule;

b) providing an apparatus comprising first and second fluid chambers in fluid communication with one another, wherein the first and second fluid chambers are separated by a structure defining a member selected from the group consisting of a nanopore, a microchannel, and a nanochannel, and wherein the apparatus comprises at least one pair of electrodes defining at least one detector volume within the structure;

c) providing at least one probe set, said probe set comprising a first plurality of identical probes that selectively hybridize to complementary regions on the target biomolecule;

d) hybridizing the probes to the target biomolecule to provide a partially hybridized biomolecule having probes hybridized to complementary regions thereon;

e) coating at least a portion of the partially hybridized biomolecule with one or more proteins;

f) translocating the partially hybridized biomolecule through the at least one detector volume;

g) monitoring, as a function of time, changes in an electrical property detected by the at least one pair of electrodes defining the at least one detector volume as the partially hybridized biomolecule translocates therethrough; and

h) differentiating between hybridized and non-hybridized regions of the target biomolecule based at least in part on the detected changes in the electrical property in the at least one detector volume, thereby mapping at least a portion of the target biomolecule.

2. The method of claim 1, wherein the biomolecule is selected from the group consisting of deoxyribonucleic acids, ribonucleic acids, and polypeptides.

3. The method of claim 1, wherein the structure defines at least one nanopore having a diameter of between about 1 nanometer and about 1 micrometer.

4. The method of claim 1, wherein the structure defines at least one microchannel having a width of between about 1 micrometer and about 25 micrometers.

5. The method of claim 1, wherein the structure defines at least one nanochannel having a width of between about 10 nanometers and about 1 micrometer.

6. The method of claim 1, wherein the at least one probe set comprises hybridizing polyamides.

7. The method of claim 1, wherein the at least one probe set comprises oligomers of non-cognate bases.

8. The method of claim 7, wherein the at least one probe set comprises at least one member selected from the group consisting of DNA, RNA, locked nucleic acid, and peptide nucleic acid.

9. The method of claim 1, wherein the at least one probe set comprises an antibody and/or a fragment thereof.

10. The method of claim 1, wherein the at least one probe set comprises hybridizing oligonucleotides having n contiguous bases capable of hybridizing to complementary regions on the biomolecule, where n is an integer from 4 to 12.

11. The method of claim 1, wherein the at least one probe set comprises gapped probes.

12. The method of claim 1, wherein at least a portion of the probes in the at least one probe set each has attached thereto a detectable tag.

13. The method of claim 12, wherein the tag does not hybridize with the biomolecule.

14. The method of claim 12, wherein the coating step includes at least partially coating at least one of the partially hybridized biomolecule and the detectable tag with one or more proteins.

15. The method of claim 12, wherein the coating step includes at least partially coating the partially hybridized biomolecule and the detectable tag with one or more proteins.

16. The method of claim 1, wherein the one or more proteins in the coating step comprises at least one member selected from the group consisting of RecA, T4 gene 32 protein, f1 geneV protein, human replication protein A, Pf3 single-stranded binding protein, adenovirus DNA binding protein, and E. coli single-stranded binding protein.

17. The method of claim 12, wherein the tag comprises a detectable identification region, thereby facilitating detection of the specific probe set to which the tag is attached.

18. The method of claim 12, wherein the tag comprises a structured biomolecule.

19. The method of claim 18, wherein the structured biomolecule has a hairpin structure.

20. The method of claim 18, wherein the tag comprises a detectable identification region, the detectable identification region comprising a unique pattern of detectable loops formed by the structured biomolecule.

21. The method of claim 1, wherein the partially hybridized biomolecule is translocated through the at least one detector volume using at least one of electrical energy, a pressure gradient, a chemical gradient, or a combination thereof.

22. The method of claim 1, wherein the changes in the electrical property are changes in electrical potential.

23. The method of claim 1, wherein the structure defines a nanopore, and the at least one pair of electrodes defines the at least one detector volume across the nanopore.

24. The method of claim 1, wherein the structure defines a microchannel, and the two paired electrodes of one or more of the at least one pair of electrodes are laterally offset with respect to each other to define a detector volume therebetween.

25. The method of claim 1, wherein the structure defines a microchannel, and the two paired electrodes of one or more of the at least one pair of electrodes are positioned across the channel with substantially no lateral offset with respect to each other.

26. The method of claim 1, wherein the structure defines a nanochannel, and the two paired electrodes of one or more of the at least one pair of electrodes are laterally offset with respect to each other to define a detector volume therebetween.

27. The method of claim 1, wherein the structure defines a nanochannel, and the two paired electrodes of one or more of the at least one pair of electrodes are positioned across the channel with substantially no lateral offset with respect to each other.

28. A method for sequencing a target biomolecule, the method comprising the step of processing the biomolecule map derived using the method of claim 1 along with short-read data, thereby identifying at least a partial sequence of the target biomolecule.

29. The method of claim 1, further comprising sequencing at least a portion of the target biomolecule by repeating steps d) to h) with a second plurality of probes having a known sequence, wherein the known sequence of the second plurality of probes at least partially overlaps a known sequence of the first plurality of probes.

30. A method for sequencing a target biomolecule, the method comprising the steps of:

a) providing a single-stranded or a double-stranded target biomolecule;

b) providing an apparatus comprising first and second fluid chambers in fluid communication with one another, wherein the first and second fluid chambers are separated by a structure defining a member selected from the group consisting of a nanopore, a microchannel, and a nanochannel, and wherein the apparatus comprises at least one pair of electrodes defining at least one detector volume within the structure;

c) providing at least two probe sets, each of said probe sets comprising a plurality of identical probes that selectively hybridize to complementary regions on the target biomolecule, each probe set hybridizing to a different complementary region, wherein at least one region complementary to the first probe set shares a subregion that is complementary to the second probe set;

d) hybridizing the first probe set to a first sample of the target biomolecule to provide a first partially hybridized biomolecule sample having first probes hybridized to complementary regions thereon;

e) at least partially coating the first partially hybridized biomolecule sample with one or more proteins;

f) translocating the first partially hybridized biomolecule sample through the detector volume;

g) monitoring, as a function of time, changes in an electrical property detected by the at least one pair of electrodes defining the at least one detector volume as the first partially hybridized biomolecule sample translocates therethrough;

h) differentiating between hybridized and non-hybridized regions of the first target biomolecule sample based at least in part on the detected changes in the electrical property in the at least one detector volume;

i) hybridizing the second probe set to a second sample of the target biomolecule to provide a second partially hybridized biomolecule sample having second probes hybridized to complementary regions thereon;

j) at least partially coating the second partially hybridized biomolecule sample with one or more proteins;

k) translocating the second partially hybridized biomolecule sample through the detector volume;

l) monitoring, as a function of time, changes in an electrical property detected by the at least one pair of electrodes defining the at least one detector volume as the second partially hybridized biomolecule sample translocates therethrough;

m) differentiating between hybridized and non-hybridized portions of the second target biomolecule sample based at least in part on the detected changes in the electrical property in the at least one detector volume; and

n) assembling correlated data sets from the first target biomolecule sample and the second target biomolecule sample, thereby sequencing at least a portion of the target biomolecule.

31. The method of claim 30, wherein the biomolecule is selected from the group consisting of deoxyribonucleic acids, ribonucleic acids, and polypeptides.

32. The method of claim 30, wherein the structure defines at least one nanopore having a diameter of between about 1 nm and about 1 μ

m.

33. The method of claim 30, wherein structure defines at least one microchannel having a width of between about 1 μ

m and about 25 μ

m.

34. The method of claim 30, wherein structure defines at least one nanochannel having a width of between about 10 nm and about 1 μ

m.

35. The method of claim 30, wherein at least one of the first or second probe sets comprises hybridizing polyamides.

36. The method of claim 30, wherein at least one of the first or second probe sets comprises oligomers of non-cognate bases.

37. The method of claim 36, wherein the at least one of the first or second probe sets comprises at least one member selected from the group consisting of DNA, RNA, locked nucleic acids, and peptide nucleic acids.

38. The method of claim 30 wherein at least one of the first or second probe sets comprises antibodies and/or fragments thereof.

39. The method of claim 30, wherein at least one of the first or second probe sets comprises hybridizing oligonucleotides having n number of contiguous bases capable of hybridizing to complementary regions on the biomolecule, where n is an integer from 4 to 12.

40. The method of claim 30, wherein at least one of the first or second probe sets comprises gapped probes.

41. The method of claim 40, wherein the gapped probes have 6 contiguous bases capable of hybridizing to complementary regions on the biomolecule.

42. The method of claim 30 wherein at least a portion of the probes in at least one of the first or second probe sets each has attached thereto a detectable tag.

43. The method of claim 42, wherein the tag does not hybridize with the biomolecule.

44. The method of claim 42, wherein the coating step includes at least partially coating at least one of the partially hybridized biomolecule and the detectable tag with one or more proteins.

45. The method of claim 42, wherein the coating step includes at least partially coating the partially hybridized biomolecule and the detectable tag with one or more proteins.

46. The method of claim 30, wherein the one or more proteins in the coating step comprises at least one member selected from the group consisting of RecA, T4 gene 32 protein, f1 geneV protein, human replication protein A, Pf3 single-stranded binding protein, adenovirus DNA binding protein, and E. coli single-stranded binding protein.

47. The method of claim 42, wherein the tag contains a detectable identification region unique to its probe set, thereby allowing the specific probe set with which the tag is included to be identified.

48. The method of claim 42, wherein the tag comprises a structured biomolecule.

49. The method of claim 48, wherein the structured biomolecule has a hairpin structure.

50. The method of claim 48, wherein the tag comprises a detectable identification region, the detectable identification region comprising a unique pattern of detectable loops formed in the structured biomolecule.

51. The method of claim 30, wherein the first and second partially hybridized biomolecule samples are translocated through the detector volume using at least one of electrical energy, a pressure gradient, a chemical gradient, or a combination thereof.

52. The method of claim 30, wherein the changes in the electrical property are changes in electrical potential.

53. The method of claim 30, wherein the structure defines a nanopore, and the at least one pair of electrodes defines at least one detector volume across the nanopore.

54. The method of claim 30, wherein the structure defines a microchannel, and the two paired electrodes of the one or more of the at least one pair of electrodes are laterally offset with respect to each other to define a detector volume therebetween.

55. The method of claim 30, wherein the structure defines a microchannel, and the two paired electrodes of one or more of the at least one pair of electrodes are positioned across the channel with substantially no lateral offset with respect to each other.

56. The method of claim 30, wherein the structure defines a nanochannel, and the two paired electrodes of one or more of the at least one pair of electrodes are laterally offset with respect to each other to define a detector volume therebetween.

57. The method of claim 30, wherein the at least two probe sets comprises a series of different probe sets each having a known sequence, the method further comprising repeating steps d) to h) for each of the series of different probe sets to produce a series of data sets differentiating between hybridized and non-hybridized portions of the target biomolecule, wherein step n) comprises assembling the series of data sets corresponding to the series of hybridizations to thereby sequence at least a portion of the target biomolecule.

58. The method of claim 30, wherein the structure defines a nanochannel, and the two paired electrodes of one or more of the at least one pair of electrodes are positioned across the channel with substantially no lateral offset with respect to each other.

59. An apparatus for analyzing a target biomolecule, the apparatus comprising:

a) first and second fluid chambers in fluid communication with one another, wherein the first and second fluid chambers are separated by a structure defining at least one nanopore;

at least one pair of electrodes positioned on opposite sides of the structure and defining a detector volume therethrough, the electrodes being in communication with an electrical signal detector and data collection device for respectively detecting and recording changes in an electrical property as the target biomolecule translocates through the detector volume; and

c) a driving force generator for translocating the target biomolecule from the first fluid chamber to the second fluid chamber through the detector volume.

60. The apparatus of claim 59, wherein the nanopore has a diameter of between about 1 nanometer and about 1 micrometer.

61. The apparatus of claim 59, wherein the changes in the electrical property are changes in an electrical current applied across the detector volume.

62. The apparatus of claim 59, wherein the driving force generator comprises at least one of electrical energy, a pressure gradient, a chemical gradient, or a combination thereof.

63. The apparatus of claim 59, further comprising:

a memory for storing code that defines a set of instructions; and

a processor for executing the set of instructions to differentiate between hybridized and non-hybridized regions of the target biomolecule based at least in part on detected changes in the electrical property as the target biomolecule translocates through the detector volume.

64. The apparatus of claim 63, wherein the processor is configured to execute the set of instructions to assemble a series of data sets differentiating between hybridized and non-hybridized portions of the target biomolecule for each of a plurality of probe-target hybridizations, thereby sequencing at least a portion of the target biomolecule, wherein the sequences of the probes are known and at least partially overlap.

65. An apparatus for analyzing a target biomolecule, the apparatus comprising:

a) first and second fluid chambers in fluid communication with one another, wherein the first and second fluid chambers are separated by a structure defining a member selected from the group consisting of a nanochannel and a microchannel;

b) at least one pair of electrodes laterally offset from one another along the channel and defining at least one detector volume therein, the electrodes being in communication with an electrical signal detector and data collection device for respectively detecting and recording changes in an electrical property as the target biomolecule translocates through the at least one detector volume; and

c) a driving force generator for translocating the target biomolecule from the first fluid chamber to the second fluid chamber through the at least one detector volume.

66. The apparatus of claim 65, wherein the structure defines a nanochannel having a width selected from a range of about 10 nm to about 1 μ

m.

67. The apparatus of claim 66, wherein the nanochannel has a depth selected from a range of about 10 nm to about 1 μ

m.

68. The apparatus of claim 67, wherein the nanochannel has a length selected from a range of about 1 μ

m to about 10 cm.

69. The apparatus of claim 68, wherein the structure defines a microchannel having a width selected from a range of about 1 μ

m to about 25 μ

m.

70. The apparatus of claim 69, wherein the microchannel has a depth selected from a range of about 200 nm to about 5 μ

m.

71. The apparatus of claim 70, wherein the microchannel has a length selected from a range of about 1 μ

m to about 10 cm.

72. The apparatus of claim 65, wherein the changes in the electrical property are changes in an electrical potential.

73. The apparatus of claim 65, wherein the driving force generator comprises at least one of electrical energy, a pressure gradient, a chemical gradient, or a combination thereof.

74. The apparatus of claim 65, further comprising:

a memory for storing code that defines a set of instructions; and

a processor for executing the set of instructions to differentiate between hybridized and non-hybridized regions of the target biomolecule based at least in part on the detected changes in electrical property as the target biomolecule translocates through the at least one detector volume.

75. The apparatus of claim 74, wherein the processor is configured to execute the set of instructions to assemble a series of data sets differentiating between hybridized and non-hybridized portions of the target biomolecule for each of a plurality of probe-target hybridizations, thereby sequencing at least a portion of the target biomolecule, wherein the sequences of the probes are known and at least partially overlap.